283 filings
Page 9 of 15
8-K
p5t muh1qnb
14 Aug 17
Fate Therapeutics Reports Second Quarter 2017 Financial Results
12:00am
8-K
fj0cgjt056rgli
14 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
yzx68 w3565
15 May 17
Fate Therapeutics Reports First Quarter 2017 Financial Results
12:00am
8-K
68vvcw
8 May 17
Submission of Matters to a Vote of Security Holders
12:00am
DEFA14A
efg5xtdx0av arvf
22 Mar 17
Additional proxy soliciting materials
12:00am
8-K
l2b0r1kw tipg
16 Mar 17
Fate Therapeutics Reports Fourth Quarter 2016 Financial Results
12:00am
PRE 14A
anx7o3x
28 Feb 17
Preliminary proxy
12:00am
S-8
srj fvgi4
3 Feb 17
Registration of securities for employees
12:00am
424B3
23aihht
25 Jan 17
Prospectus supplement
12:00am
EFFECT
41bg3yk5mxe0gx0u3b
24 Jan 17
Notice of effectiveness
12:00am
CORRESP
0gkzb213q8 80
20 Jan 17
Correspondence with SEC
12:00am
UPLOAD
y6c jpnz34ixhdourhq0
18 Jan 17
Letter from SEC
12:00am
D
1kyhvx h05
8 Dec 16
$56.75M in equity, sold $56.75M, 21 investors
12:00am
8-K
mvw29ww142
29 Nov 16
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
01m8zc6l0nai
22 Nov 16
Fate Therapeutics Announces Private Financing
12:00am